Activists Relaunch Bid to Get University of Oregon to Supply Dangerous Abortion Pills to Students

The move comes amid federal scrutiny of the abortion pill mifepristone, triggered by a blockbuster study suggesting that the adverse reaction rate associated with the drug is far higher than previously indicated by the FDA.